Even as advances in treatment and testing have dramatically improved the length and quality of life for people with HIV, at least 20% are unaware of their positive status. In response, healthcare providers have been working hard at refining the implementation of the 2006 CDC recommendation for non-targeted HIV screening of all patients age 13–64 in healthcare settings.
Although antiplatelet therapy is a well-established tool for managing patients with cardiovascular disease, less is known about the window for discontinuing antiplatelet therapy prior to surgery. Based on guidelines and emerging evidence, clinicians now are beginning to incorporate platelet function testing into protocols for determining the optimal time for surgery for each patient.
Advancements in therapeutic drug monitoring of immunosuppressants are allowing labs to play an increasingly important role in improving the long-term survival of transplant patients.
Download the entire issue
The Lab's Role in Combating MRSAMolecular Test Coding Changes on the Horizon